Jivan and NimbleGen Partner for Splice Array Market
News Feb 03, 2006
"Jivan is proud to offer its full product line on NimbleGen's flexible and robust microarray platform," said Dr. Subha Srinivasan, CEO of Jivan Biologics (Berkeley, CA).
"This partnership furthers our goal to become the platform-independent solution for high-throughput splice variant analysis."
Dr. Stanley Rose, President and CEO of NimbleGen Systems (Madison, WI), commented, "Our collaboration with Jivan provides yet another example of an emerging measure of genome function or activity being enabled by NimbleGen’s platform."
"This product line nicely complements our whole genome ChIP-chip, CGH, Comparative Genome Sequencing, and Expression offerings, and further expands our integrated analytical capabilities also known as High Definition Genomics."
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019